LONG-TERM DRUG SURVIVAL OF ETANERCEPT VS OTHER TNF INHIBITOR THERAPIES IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Emery, P. [1 ]
Vlahos, B. [2 ]
Szczypa, P. [3 ]
Thakur, M. [4 ]
Jones, H. E. [2 ]
Woolcott, J. [2 ]
Estrella, P. V. Santos [2 ]
Gibofsky, A. [5 ]
Rolland, C. [6 ]
Citera, G. [7 ]
Marshall, L. [2 ]
机构：
[1] Leeds Inst Rheumat & Musculoskeletal Med, Leeds Musculoskeletal Biomed Res Ctr LTHT, Leeds, W Yorkshire, England
[2] Pfizer, Collegeville, PA USA
[3] Pfizer Ltd, Walton Oaks, GA USA
[4] Pfizer, Sandwich, Kent, England
[5] Weill Med Coll, New York, NY USA
[6] Envis Pharma Grp, Horsham, W Sussex, England
[7] Consultorios Reumatol, Buenos Aires, DF, Argentina
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.2504
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0460
引用
收藏
页码：1391 / 1392
页数：3
相关论文
共 50 条
  • [31] Compliance in the Rheumatoid Arthritis Comparison of Active Therapies Trial: Triple Vs Etanercept
    Leatherman, Sarah
    Wu, Hongsheng
    Keystone, Edward
    Brophy, Mary
    O'Dell, James
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1033 - S1033
  • [32] Drug-survival, effectiveness and safety of infliximab, adalimumab and etanercept in rheumatoid arthritis patients
    Flendrie, M.
    Creemers, M. C. W.
    Welsing, P. M. J.
    Van den Hoogen, F. H. J.
    Van Riel, P. L. C. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 191 - 191
  • [33] LONG-TERM EFFECTIVENESS AND SAFETY OF ADALIMUMAB IN PATIENTS WITH MODERATE VS SEVERE RHEUMATOID ARTHRITIS
    Burmester, Gerd R.
    Matucci-Cerinic, Marco
    Navarro-Blasco, Francisco
    Kary, Sonja
    Unnebrink, Kristina
    Kupper, Hartmut
    RHEUMATOLOGY, 2013, 52 : 81 - 81
  • [34] Impact of long-term anti-TNF-α treatment on insulin resistance in patients with rheumatoid arthritis
    Seriolo, B.
    Paolino, S.
    Ferrone, C.
    Cutolo, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (01) : 159 - 160
  • [35] Influence of Immunogenicity on the Efficacy of Long-Term Treatment with TNFα Blockers in Rheumatoid Arthritis and Spondyloarthritis Patients
    Arstikyte, Inesa
    Kapleryte, Giedre
    Butrimiene, Irena
    Venalis, Algirdas
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [36] Long-Term Survival of Biological Therapy in Rheumatoid Arthritis Elderly Patients in Clinical Practice
    Lajas, Cristina
    Gomez-Gomez, Alejandro
    Rodriguez-Rodriguez, Luis
    Leon, Leticia
    Vadillo, Cristina
    Freites Nunez, Dalifer
    Macarron, Pilar
    Leal Pozuelo, Jose Maria
    Jover, Juan A.
    Abasolo, Lydia
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [37] ENBREL® (etanercept) in addition to methotrexate (MTX) in rheumatoid arthritis (RA):: Long-term observations
    Burge, DJ
    Weinblatt, ME
    Kremer, JM
    Fleischmann, RM
    Bankhurst, AD
    Bulpitt, KJ
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 106 - 106
  • [38] Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry
    Atzeni, Fabiola
    Sarzi-Puttini, Piercarlo
    Botsios, Costantino
    Carletto, Antonio
    Cipriani, Paola
    Favalli, Ennio Giulio
    Frati, Elena
    Foschi, Valentina
    Gasparini, Stefania
    Giardina, AnnaRita
    Gremese, Elisa
    Iannone, Florenzo
    Sebastiani, Marco
    Ziglioli, Tamara
    Biasi, Domenico
    Ferri, Clodoveo
    Galeazzi, Mauro
    Gerli, Roberto
    Giacomelli, Roberto
    Gorla, Roberto
    Govoni, Marcello
    Lapadula, Giovanni
    Marchesoni, Antonio
    Salaffi, Fausto
    Punzi, Leonardo
    Triolo, Giovanni
    Ferraccioli, Gianfranco
    AUTOIMMUNITY REVIEWS, 2012, 12 (02) : 225 - 229
  • [39] Long-term safety of Etanercept in patients with juvenile idiopathic arthritis (JIA)
    Minden, K.
    Klotsche, J.
    Niewerth, M.
    Horneff, G.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 13 - 13
  • [40] SURVIVAL ANALYSIS OF TIME TO FIRST ADVERSE DRUG REACTION AND DRUG SURVIVAL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ADALIMUMAB AND ETANERCEPT
    Nguyen, M.
    Velthuis, K.
    Scholl, J.
    Jansen, J.
    Kosse, L.
    Ten Klooster, P.
    Jessurun, N.
    Vonkeman, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1122 - 1122
12345